Clinical Trial Update: Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing immediate versus deferred empirical voriconazole therapy in neutropenic patients at risk for fungal infection; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Possible Fungal Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-08-18